Can drug price hikes via debranding be prevented?

Bokhari, Farasat and Lyons, Bruce (2017) Can drug price hikes via debranding be prevented? Prescriber, 28 (4). pp. 44-46.

[img]
Preview
PDF (Accepted manuscript) - Submitted Version
Download (171kB) | Preview

    Abstract

    Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?

    Item Type: Article
    Faculty \ School: Faculty of Social Sciences > School of Economics
    Related URLs:
    Depositing User: Pure Connector
    Date Deposited: 12 May 2017 06:05
    Last Modified: 09 Apr 2019 12:11
    URI: https://ueaeprints.uea.ac.uk/id/eprint/63483
    DOI: 10.1002/psb.1563

    Actions (login required)

    View Item